Skip to content
Search

Latest Stories

Top Stories

Three major health care battles taking shape in 2024

People protesting Dobbs decision

People protested on the first anniversary of the Supreme Court's June 2022 decision in the Dobbs case. The court may further limit abortion rights this year.

Celal Gunes/Anadolu Agency via Getty Images

Pearl is a clinical professor of plastic surgery at the Stanford University School of Medicine and is on the faculty of the Stanford Graduate School of Business. He is a former CEO of The Permanente Medical Group.

Modern medicine, for most of its history, has operated within a collegial environment — an industry of civility where physicians, pharmaceutical companies and hospitals stayed in their lanes and out of each other’s business.

Times have changed as health care has taken a 180-degree turn. This year will be characterized by cutthroat competition and intense disputes played out in public. And as the once harmonious world of health care braces for battle, three critical struggles take center stage. Each promises controversy and profound implications for the future of medicine.

The first battle involves abortion rights.


For nearly 50 years — from the landmark Roe v. Wade decision in 1973 to its overruling by the 2022 Dobbs case — abortion decisions were the province of women and their doctors. This dynamic has changed in nearly half the states.

This spring, the Supreme Court is set to hear another pivotal case. It concerns mifepristone, an important drug for medical abortions. The ruling, expected in June, will significantly impact women’s rights, as well as federal regulatory bodies like the Food and Drug Administration.

Traditionally, abortions were surgical procedures. Today, over half are medically induced, primarily using a two-drug combination that includes mifepristone. Since its approval in 2000, mifepristone has been prescribed to over 5 million women, and it boasts an excellent safety record.

But anti-abortion groups have proposed stringent legal restrictions: reducing the administration window from 10 to seven weeks post-conception, banning distribution of the drug by mail, and mandating three in-person doctor visits, a burdensome requirement for many.

While physicians would still be allowed to prescribe misoprostol (the second drug in the regimen), its effectiveness alone pales in comparison to the two-drug combo.

Should the Supreme Court overrule the FDA’s clinical expertise on these matters, abortion activists fear the floodgates will open, inviting new challenges against other established medications like birth control.

In response, several states have fortified abortion rights through ballot initiatives, a trend expected to gain momentum in the November elections. This legislative action underscores a significant public-opinion break from the Supreme Court’s stance. In fact, a survey published in Nature Human Behavior reveals that 60 percent of Americans support legal abortion.

Who will win this battle? That’s unclear. Traditionally, the court’s rulings have mirrored public opinion on key social issues, but the gap is large on abortion rights. This sets the stage for an even fiercer clash in years to come. A Supreme Court ruling that renders abortion unconstitutional would contradict the principles outlined in Dobbs and recent protections passed by the states. As a result, America’s divide on abortion rights is poised to deepen.

The second battle involves the use of generative AI in medicine.

A year after ChatGPT’s release, artificial intelligence is already reshaping entire industries. In health care, insurers are leveraging AI to speed up and intensify claim denials, prompting providers to counter with AI-assisted appeals.

Beyond corporate skirmishes, the most profound AI conflict involves the doctor-patient relationship. Physicians, already vexed by patients who self-diagnose with “Dr. Google,” find themselves unsure whether generative AI will be friend or foe.

Studies conclude that generative AI can already diagnose and recommend treatments with remarkable accuracy and empathy, surpassing human doctors in ever-more ways. And unlike traditional search engines, generative AI doesn’t just spit out unfiltered, generic information. It provides nuanced and personalized insights based on terabytes of up-to-date medical research and the patient’s own health data.

Who will win this battle? Whoever embraces these tools faster and more intelligently. While doctors are already taking advantage of AI’s administrative benefits (billing, notetaking and data entry), they’re apprehensive that ChatGPT will lead to errors if used for patient care. But five years from now, with ChatGPT predicted to be 30 times more powerful, generative AI systems will become safer, more reliable and integral to medical care. Advanced tools, interfacing with wearables and electronic health records, will aid with disease management, diagnosis and chronic-condition monitoring, enhancing clinical outcomes, and overall health.

The final battle features a tug-of-war over health care pricing.

From routine doctor visits to complex hospital stays and drug prescriptions, every aspect of U.S. health care is getting more expensive. That’s not news to most Americans, half of whom say it is very or somewhat difficult to afford health care costs.

Throughout U.S. health care, financial pressures are increasing. Hospitals are consolidating. Nurses are striking. And thousands of physicians have sold their medical practices to private equity firms.

This trend will continue in 2024 and likely drive up prices, as much as 30 percent higher for many specialties.

Drug spending, meanwhile, will soar in 2024 as weight-loss drugs (costing roughly $12,000 a year) become increasingly available. A groundbreaking sickle cell disease treatment is projected to cost nearly $3 million upon release. This year, Big Pharma will bolster its efforts to delay or overturn legislation that would allow the centers for Medicare & Medicaid Services to negotiate prices for 10 of the most expensive outpatient drugs starting in 2026.

Who will win the pricing battle? That’s up to voters. With national health care spending expected to rise from $4 trillion now to $7 trillion by 2031, the upcoming election will be pivotal in steering the financial strategy. A Republican surge could mean tighter controls on Medicare and Medicaid and relaxed insurance regulations, whereas a Democratic sweep could lead to increased taxes, especially on the wealthy. A divided government, however, would stall significant reforms, exacerbating the crisis of unaffordability.

So, is peace possible? Amid the strife, hope glimmers: The rise of ChatGPT and other generative AI technologies holds promise for empowering patients and improving clinical outcomes. The debate over abortion rights, while deeply polarizing, might eventually find resolution in a legislative middle ground that echoes Roe’s protections with some restrictions on how late in pregnancy procedures can be performed.

Unfortunately, some problems need to get worse before they can get better. I predict the affordability of health care will be one of them. My New Year’s request is to not shoot the messenger.

Read More

Just the Facts: Impact of the Big Beautiful Bill on Health Care

U.S. President Donald Trump takes the stage during a reception for Republican members of the House of Representatives in the East Room of the White House on July 22, 2025 in Washington, DC. Trump thanked GOP lawmakers for passing the One Big Beautiful Bill Act.

Getty Images, Chip Somodevilla

Just the Facts: Impact of the Big Beautiful Bill on Health Care

The Fulcrum strives to approach news stories with an open mind and skepticism, striving to present our readers with a broad spectrum of viewpoints through diligent research and critical thinking. As best we can, we remove personal bias from our reporting and seek a variety of perspectives in both our news gathering and selection of opinion pieces. However, before our readers can analyze varying viewpoints, they must have the facts.

What are the new Medicaid work requirements, and are they more lenient or more restrictive than what previously existed?

Keep ReadingShow less
U.S. Constitution
Imagining constitutions
Douglas Sacha/Getty Images

A Bold Civic Renaissance for America’s 250th

Every September 17, Americans mark Constitution Day—the anniversary of the signing of our nation’s foundational charter in 1787. The day is often commemorated with classroom lessons and speaking events, but it is more than a ceremonial anniversary. It is an invitation to ask: What does it mean to live under a constitution that was designed as a charge for each generation to study, debate, and uphold its principles? This year, as we look toward the semiquincentennial of our nation in 2026, the question feels especially urgent.

The decade between 1776 and 1787 was defined by a period of bold and intentional nation and national identity building. In that time, the United States declared independence, crafted its first national government, won a war to make their independence a reality, threw out the first government when it failed, and forged a new federal government to lead the nation. We stand at a similar inflection point. The coming decade, from the nation’s semiquincentennial in 2026 to the Constitution’s in 2037, offers a parallel opportunity to reimagine and reinvigorate our American civic culture. Amid the challenges we face today, there’s an opportunity to study, reflect, and prepare to write the next chapters in our American story—it is as much about the past 250 years, as it is about the next 250 years. It will require the same kind of audacious commitment to building for the future that was present at the nation’s outset.

Keep ReadingShow less
Texas redistricting maps

Two bills have been introduced to Congress that aim to ban mid-decade redistricting on the federal level and contain provisions making an exception for mid-decade redistricting.

Tamir Kalifa/Getty Images

Congress Bill Spotlight: Anti-Rigging Act, Banning Mid-Decade Redistricting As Texas and California Are Attempting

Trump claims Republicans are “entitled” to five more Texas House seats.

Context: in the news

In August, the Republican-controlled Texas state legislature approved a rare “mid-decade” redistricting for U.S. House seats, with President Donald Trump’s encouragement.

Keep ReadingShow less
Independent Madness- or How the Cheshire Cat Can Slay the Gerrymander

The Cheshire Cat (John Tenniel) Devouring the Gerrymander (Elkanah Tisdale )

Independent Madness- or How the Cheshire Cat Can Slay the Gerrymander

America has a long, if erratic, history of expanding its democratic franchise. Over the last two centuries, “representation” grew to embrace former slaves, women, and eighteen-year-olds, while barriers to voting like literacy tests and outright intimidation declined. Except, that is, for one key group, Independents and Third-party voters- half the electorate- who still struggle to gain ballot access and exercise their authentic democratic voice.

Let’s be realistic: most third parties aren't deluding themselves about winning a single-member election, even if they had equal ballot access. “Independents” – that sprawling, 40-percent-strong coalition of diverse policy positions, people, and gripes – are too diffuse to coalesce around a single candidate. So gerrymanderers assume they will reluctantly vote for one of the two main parties. Relegating Independents to mere footnotes in the general election outcome, since they’re also systematically shut out of party primaries, where 9 out of 10 elections are determined.

Keep ReadingShow less